A citation-based method for searching scientific literature

C J Ferro, J C Spratt, W G Haynes, D J Webb. Circulation 1998
Times Cited: 140







List of co-cited articles
1010 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Angiotensin-neprilysin inhibition versus enalapril in heart failure.
John J V McMurray, Milton Packer, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. N Engl J Med 2014
49

Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi).
Jessie Gu, Adele Noe, Priya Chandra, Suliman Al-Fayoumi, Monica Ligueros-Saylan, Ramesh Sarangapani, Suzanne Maahs, Gary Ksander, Dean F Rigel, Arco Y Jeng,[...]. J Clin Pharmacol 2010
355
45

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).
Milton Packer, Robert M Califf, Marvin A Konstam, Henry Krum, John J McMurray, Jean-Lucien Rouleau, Karl Swedberg. Circulation 2002
474
43


Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial.
John B Kostis, Milton Packer, Henry R Black, Roland Schmieder, David Henry, Elliott Levy. Am J Hypertens 2004
378
41

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.
Scott D Solomon, Michael Zile, Burkert Pieske, Adriaan Voors, Amil Shah, Elisabeth Kraigher-Krainer, Victor Shi, Toni Bransford, Madoka Takeuchi, Jianjian Gong,[...]. Lancet 2012
787
34


Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial.
J L Rouleau, M A Pfeffer, D J Stewart, D Isaac, F Sestier, E K Kerut, C B Porter, G Proulx, C Qian, A J Block. Lancet 2000
324
27

Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension.
E G Bevan, J M Connell, J Doyle, H A Carmichael, D L Davies, A R Lorimer, G T McInnes. J Hypertens 1992
128
26

Effect of nesiritide in patients with acute decompensated heart failure.
C M O'Connor, R C Starling, A F Hernandez, P W Armstrong, K Dickstein, V Hasselblad, G M Heizer, M Komajda, B M Massie, J J V McMurray,[...]. N Engl J Med 2011
878
25

Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.
Milton Packer, John J V McMurray, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. Circulation 2015
447
23

Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema.
R M Fryer, J Segreti, P N Banfor, D L Widomski, B J Backes, C W Lin, S J Ballaron, B F Cox, J M Trevillyan, G A Reinhart,[...]. Br J Pharmacol 2008
100
22

Effects of UK 69 578: a novel atriopeptidase inhibitor.
D B Northridge, A G Jardine, C T Alabaster, P L Barclay, J M Connell, H J Dargie, S G Dilly, I N Findlay, A F Lever, G M Samuels. Lancet 1989
216
21

Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Asian patients with hypertension: a randomized, double-blind, placebo-controlled study.
Kazuomi Kario, Ningling Sun, Fu-Tien Chiang, Ouppatham Supasyndh, Sang Hong Baek, Akiko Inubushi-Molessa, Ying Zhang, Hiromi Gotou, Martin Lefkowitz, Jack Zhang. Hypertension 2014
152
21

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
Salim Yusuf, Bertram Pitt, Clarence E Davis, William B Hood, Jay N Cohn. N Engl J Med 1991
19

Natriuretic peptides.
E R Levin, D G Gardner, W K Samson. N Engl J Med 1998
19


Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics.
Sarah Mangiafico, Lisa C Costello-Boerrigter, Ingrid A Andersen, Alessandro Cataliotti, John C Burnett. Eur Heart J 2013
169
18

The effect of the neutral endopeptidase inhibitor drug, candoxatril, on circulating levels of two of the most potent vasoactive peptides.
G McDowell, W Coutie, C Shaw, K D Buchanan, A D Struthers, D P Nicholls. Br J Clin Pharmacol 1997
77
22



Vasopeptidase inhibition: a double-edged sword?
Duncan John Campbell. Hypertension 2003
95
16






Chronic inhibition of endopeptidase 24.11 in essential hypertension: evidence for enhanced atrial natriuretic peptide and angiotensin II.
A M Richards, G A Wittert, I G Crozier, E A Espiner, T G Yandle, H Ikram, C Frampton. J Hypertens 1993
121
13



Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.
Laxminarayan G Hegde, Cecile Yu, Travis Renner, Harold Thibodeaux, Scott R Armstrong, Timothy Park, Madhavi Cheruvu, Rachael Olsufka, Erik R Sandvik, Cassie E Lane,[...]. J Cardiovasc Pharmacol 2011
51
25

Natriuretic peptides.
Lori B Daniels, Alan S Maisel. J Am Coll Cardiol 2007
751
12

Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy.
Thomas G von Lueder, Bing H Wang, Andrew R Kompa, Li Huang, Randy Webb, Pierre Jordaan, Dan Atar, Henry Krum. Circ Heart Fail 2015
203
12

Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients.
Akshay S Desai, John J V McMurray, Milton Packer, Karl Swedberg, Jean L Rouleau, Fabian Chen, Jianjian Gong, Adel R Rizkala, Abdel Brahimi, Brian Claggett,[...]. Eur Heart J 2015
270
12


Effect of inhibition of endopeptidase 24.11 on responses to angiotensin II in human volunteers.
A M Richards, G A Wittert, E A Espiner, T G Yandle, H Ikram, C Frampton. Circ Res 1992
74
14

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Mark H Drazner, Gregg C Fonarow, Stephen A Geraci, Tamara Horwich, James L Januzzi,[...]. J Am Coll Cardiol 2013
11





Dicarboxylic acid dipeptide neutral endopeptidase inhibitors.
G M Ksander, R D Ghai, R deJesus, C G Diefenbacher, A Yuan, C Berry, Y Sakane, A Trapani. J Med Chem 1995
45
22

Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial.
Pardeep S Jhund, Brian Claggett, Milton Packer, Michael R Zile, Adriaan A Voors, Burkert Pieske, Martin Lefkowitz, Victor Shi, Toni Bransford, John J V McMurray,[...]. Eur J Heart Fail 2014
64
15


Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF.
Pardeep S Jhund, Michael Fu, Edmundo Bayram, Chen-Huan Chen, Marta Negrusz-Kawecka, Arvo Rosenthal, Akshay S Desai, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau,[...]. Eur Heart J 2015
155
10

Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research study.
Gary F Mitchell, Joseph L Izzo, Yves Lacourcière, Jean-Pascal Ouellet, Joel Neutel, Chunlin Qian, Linda J Kerwin, Alan J Block, Marc A Pfeffer. Circulation 2002
186
9

Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
J A Robl, C Q Sun, J Stevenson, D E Ryono, L M Simpkins, M P Cimarusti, T Dejneka, W A Slusarchyk, S Chao, L Stratton,[...]. J Med Chem 1997
135
9

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.
W S Colucci, U Elkayam, D P Horton, W T Abraham, R C Bourge, A D Johnson, L E Wagoner, M M Givertz, C S Liang, M Neibaur,[...]. N Engl J Med 2000
701
9


Eplerenone in patients with systolic heart failure and mild symptoms.
Faiez Zannad, John J V McMurray, Henry Krum, Dirk J van Veldhuisen, Karl Swedberg, Harry Shi, John Vincent, Stuart J Pocock, Bertram Pitt. N Engl J Med 2011
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.